Stanley-Laman Group’s Affimed AFMD Stock Holding History

Stanley-Laman Group’s Portfolio AFMD Stock Details AFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-6,069	Closed	-$100K	–	220
2018 Q2	$100K	Buy	+6,069	New	+$128K	0.02%	260

Other funds holding AFMD

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCPEM

Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

EGI

EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Stanley-Laman Group's AFMD Position: Q3 2018 in Review

Stanley-Laman Group sold out of Affimed (AFMD) in Q3 2018, closing a stake of 6,069 shares — an estimated $100K sold.

Stanley-Laman Group first reported a position in AFMD in Q2 2018 and held it in 1 quarter. The position peaked at $100K in Q2 2018. 53 funds tracked by Wall St. Rank hold AFMD as of Q3 2018.

Stanley-Laman Group reported no remaining Affimed position as of Q3 2018 after selling out during the quarter.
Stanley-Laman Group sold 6,069 Affimed shares in Q3 2018, an estimated $100K.
Stanley-Laman Group first reported a position in Affimed in Q2 2018 and held it in 1 quarter.
Stanley-Laman Group's Affimed position peaked at $100K in Q2 2018.
53 funds tracked by Wall St. Rank held Affimed as of Q3 2018.

Based on Stanley-Laman Group's 13F filing for Q3 2018, filed 30 Oct 2018.